Hepatitis C: the dermatologic profile

Farhana Muzaffar, Ijaz Hussain, Tahir Saeed Haroon

Abstract


The hepatitis C virus (HCV) is a major public health problem all over the world with a global prevalence of 3%. It is responsible for 70% of cases of chronic hepatitis, the major cause of cirrhosis and the most common cause of hepatocellular carcinoma. The current treatment of chronic hepatitis C is the combination of interferon alpha and ribavirin with the sustained treatment response range of 56-82%.

 

Chronic hepatitis C is associated with a plethora of extrahepatic manifestations including dermatological disorders e.g. mixed cryoglobulinemia, porphyria cutanea tarda, lichen planus, pruritus and other less common conditions. The current review focuses on the dermatologic perspective of HCV infection highlighting the need of screening patients of different dermatoses for HCV in order to prevent the development of terminal, life-threatening consequences and further transmission of HCV.

 


Keywords


Hepatitis C, skin manifestations, dermatologic profile

Full Text:

PDF

References


WHO. Hepatitis C [internet]. Geneva: WHO. C2004 [cited 15.07.2008]. Available from: http//www.who.int/mediacentre/factssheets/fs164/en/

Bonkovsky HL, Mehta S, Hepatitis C: A review and update. J Am Acad Dermatol 2001; 44: 159-79.

Maticic M. Hepatitis C virus infection: the dermatological perspective. Acta Dermatoven APA 2003; 12: 19-27.

Chung CM, Nunley JR. Overview of hepatitis C and skin. Dermatol Nurs 2006; 18: 425-30.

Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev Immunol 2004: 5: 215-9.

Schwartz RA, Birnkrant AP. Cutaneous manifestations of hepatitis C. Available from www.emedicine.com/derm/hepatitis C. Accessed on 17.02.2008.

Mohsin A. Pakistan: a cirrhotic state in need of a savior! (editorial). Esculapio 2006; 2: 1.

Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008; 8: 69.

Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008; 41: 4-8.

Chaudhary IA, Samiullah, Khan SS et al. Seroprevalence of hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. Pak J Med Sci 2007; 23: 64-7.

Jehangir W, Ali F, Shahnawaz U et al. Prevalence of hepatitis B, C and HIV in blood donors of South Punjab. Esculapio 2006; 2: 6-7.

Muhammad N, Jan A. Frequency of hepatitis C in Buner, NWFP. J Coll Physicians Surg Pak 2005; 15: 11-4.

Khokhar N, Gill ML, Malik GA. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 534-6.

Kazmi K, Sadaruddin A, Dil AS, Zuberi SJ. Prevalence of HCV in blood donors. Pak J Med Res 1997; 36: 61-2.

Khan MSA, Khalid M, Ayub N, Javed M. Seroprevalence and risk factors of Hepatitis C virus (HCV) in Mardan, N.W.F.P. Rawal Med J 2004; 29: 57-60.

Hashmie ZY, Chaudhary AH, Ahmad M, Ashraf M. Incidence of anti-hepatitis C virus positivity in healthy voluntary blood donors at Faisalabad. Professional 1999; 6: 551-5.

Tariq W, Hussain AB, Karamat KA et al. Demographic aspects of hepatitis C in Northern Pakistan. J Pak Med Assoc 1999; 49: 198-201.

Shamsi T, Ahmad A, Taj Z. Prevalence of hepatitis B, C and HIV virus infection among beta thalassaemia major patients. Pak J Med Res 1998; 48: 87.

Fayyaz H, Latif Y, Sohail R, Zaman F. Screening for hepatitis C in gynecological population. Ann King Edward Med Coll 2004; 10: 287-8.

Hakeem A, Khan MS, Abdullah M et al. Prevalence of HBs & anti-HCV in pregnant ladies attending antenatal clinic at Sheikh Zayed Medical Complex, Rahim Yar Khan. Esculapio 2006; 2: 8-10.

Idrees M, Lal A, Naseem M, Khalid M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008; 9: 95-103.

Foster G, Mathurin P. Hepatitis C virus therapy to date. Antivir Ther 2008; 13 Suppl 1: 3-8.

Azafar NA, Zaman T, Rashid T, Jahangir M. Cutaneous manifestations in patients of hepatitis C. J Pak Assoc Dermatol 2008; 18: 138-43.

Dervis E, Serez K. The prevalence of dermatologic manifestations related to chronic hepatitis C virus infection in a study from a single center in Turkey. Acta Dermatoven APA, 2005; 14: 93-8.

Paoletti V, Mammarella A, Basili S et al. Prevalence and clinical features of skin disease in chronic hepatitis C infection. A prospective study in 96 patients. Panmineva Med 2002; 44: 349-52.

de Sanjose S, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-8..

Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994; 31: 1070-2.

Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Inv 1995; 25: 910-4.

Grote M, Reichart PA, Berg T, Hops U. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 1998; 29: 1034-5.

Shahid M. HCV seropositivity in patients with lichen planus (dissertation for fellowship). Karachi: College of Physicians and Surgeons Pakistan; 2003.

Mignogna MD, Muzio LL, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998; 37: 575-8.

Maticic M, Poljak M, Kramar B et al. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. J Periodontol 2001; 72: 11-16.

Divano MC, Prodi A, Rebora A. Anti-GOR antibodies in lichen planus. Dermatology 1994; 188: 205-6.

Abdallah MA, Ghozzi MY, Monib HA et al. Necrolytic acral erythema: A cutaneous sign of hepatitis C virus infection. J Am Acad Dermatol 2005: 53: 247-51.

Hivnor CM, Yan AC,. Junkins-Hopkins JM, Honig PJ. Necrolytic acral erythema: Response to combination therapy with interferon and ribavirin. J Am Acad Dermatol 2004; 50: S121-4.

Cribier BJ, Santinelli F, Schmitti C et al. Chronic urticaria is not significantly associated with hepatitis C virus or hepatitis G virus infection: a case control study. Arch Dermatol 1999; 135: 1335-9.

Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996; 35: 195-8.

Ahmed I, Wahid Z, Ahmed Z. Chronic urticaria: frequency of anti-HCV antibodies. J Pak Assoc Dermatol 2003; 13: 179-83.

Malik LM, Mufti S, Saeed S et al. Hepatitis C seropositivity in patients with acute and chronic urticaria. J Pak Assoc Dermatol 2008; 18: 144-8.

Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Dis 2008; 14: 123-30.

Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol 1998; 39: 824-6.

D'Alessandro-Gandolfo L, Biocaiti G, Griso D, Marci A, Topi G. Frequency of viral hepatitis markers in porphyria cutanea tarda. Eur J Dermatol 1993; 3: 180-2.

Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B virus infection: a retrospective study. Hepatology 1995; 21: 279-84.

Aamir S, Ullah Z, Iqbal Z, Khan AA, Yaqub F, Malik K. Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C. J Pak Assoc Dermatol 2008; 18: 14-20.

Takeshi Kono T, Kobayashi H, Masamitsu Ishii M et al. Synchronous development of disseminated superficial porokeratosis and hepatitis C virusrelated hepatocellular carcinoma. J Am Acad Dermatol 2000; 43: 966-8.

Ota M, Sato-Matsumura KC, Sawamura D, Shimizu H. Papuloerythroderma associated with hepatitis C virus infection. J Am Acad Dermatol 2005; 5: S61-2.

Granel B, Serratrice J, Rey J et al. Chronic hepatitis C virus infection associated with a generalized granuloma annulare. J Am Acad Dermatol 2000; 43: 918-9.

Azfar NA, Zaman T, Khan AR, Jahangir M. Scleromyxedema in an HCV-positive male. J Pak Assoc Dermatol 2008; 18: 116-8.

Rongioletti F, Rebora A. Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C. J Am Acad Dermatol 1998; 38: 760-1.

Shook BA, Wells MJ, Rapini RP, Cobos E. Epidermolysis bullosa acquisita occurring in 2 patients with hepatitis C. J Am Acad Dermatol 2006; 54: 888-91.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014